SiriusPoint Ltd Ordinary Shares SPNT 深 沪
等待开盘 07-26 09:30:00 美东时间
19.79
+0.210
+1.07%
华盛通- 最 高19.84
- 今 开19.73
- 成交量 84.78万股
- 最 低 19.52
- 昨 收 19.58
- 总市值 23.15亿
- 52周最高 21.03
- 市盈率 静 19.03
- 换手率 0.72%
- 52周最低 12.78
- 委 比 -96.32%
- 总股本 1.17亿
- 历史最高 21.03
- 量 比 1.30
- 振 幅 1.63%
- 历史最低 4.07
- 每 手 1
- 风险率 1.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多B. Riley Securities Initiates Coverage On SiriusPoint with Buy Rating, Announces Price Target of $30
B. Riley Securities analyst Randy Binner initiates coverage on SiriusPoint (NYSE:SPNT) with a Buy rating and announces Price Target of $30.
07-21 20:25
SiriusPoint Announces Date for Second Quarter 2025 Earnings Release
SiriusPoint Ltd. plans to release its Q2 2025 financial results before markets open on August 4, 2025. A conference call at 8:30 a.m. ET on the same day will discuss the results, accessible via the company's website or phone. A replay will be available post-call. SiriusPoint is a global underwriter of insurance and reinsurance, headquartered in Bermuda with offices worldwide, listed on the NYSE as SPNT. For more details, visit www.siriuspt.com.
07-21 20:10
美股大行评级 | 潜在涨幅61.27%！Loop Capital上调英伟达目标价至250美元，维持"买入"评级
今日重点评级关注：Benchmark：维持特斯拉(TSLA)"买入"评级，目标价从350美元升至475美元>>
06-27 08:37
Oppenheimer Initiates Coverage On SiriusPoint with Outperform Rating, Announces Price Target of $25
Oppenheimer analyst Michael Phillips initiates coverage on SiriusPoint (NYSE:SPNT) with a Outperform rating and announces Price Target of $25.
06-26 23:36
Earnings Scheduled For May 5, 2025
Companies Reporting Before The Bell • Recursion Pharmaceuticals (NASDAQ:RXRX) i...
05-05 16:32
美股大行评级 | 潜在涨幅684.71%！Verve Therapeutics获Canaccord Genuity升目标价至39美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1119185980869894144.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity：维持Verve Therapeutics(VERV)"买入"评级，目标价从32美元升至39美元</p> <p>• HC Wainwright & Co.：维持Verve Ther
04-16 09:45
Insurance stocks jump, fintechs slide: week's financials wrap
This week's five biggest gainers in the financials sector featured predominantly insurance companies, while fintechs came under pressure the most. With tariff policies still dominating headlines and d...
03-29 22:10
Reported Earlier, SiriusPoint Prices Secondary Offering Of 4.1M Shares At $14 Each, Repurchasing 500,000 Shares
SiriusPoint has agreed to repurchase an aggregate of 500,000 of the common shares being offered in the offering at the public offering price. SiriusPoint will cancel the 500,000 common shares it repurchases in the
02-26 16:00
SiriusPoint prices secondary offering at $14 per share
SiriusPoint (NYSE:SPNT) priced its previously announced registered secondary offering by entities associated with Daniel S. Loeb of an aggregate of 4.1M common shares at a price to the public of $14...
02-26 14:58
SiriusPoint Q4 EPS $(0.13) Down From $0.50 YoY, Sales $590.30M Down From $645.80M YoY
SiriusPoint (NYSE:SPNT) reported quarterly losses of $(0.13) per share. This is a 126 percent decrease over earnings of $0.50 per share from the same period last year. The company reported $590.30 million in sales this
02-19 06:02
